How might substances like LSD, psilocybins, and other hallucinogens provide relief to people suffering from conditions such as depression, addiction, and anorexia? Robin Carhart-Harris is a neuroscientist and head of the Imperial Centre for Psychedelic Research, which builds on over a decade of pioneering work including a clinical trial that has kickstarted global efforts to develop psilocybin therapy into a licensed treatment for depression. On June 29, 2020, Dr. Carhart-Harris spoke with Dr. Mellody Hayes, an anesthesiologist and founder of a psychedelic wellness clinic, by videoconference during the COVID-19 pandemic.
